End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7.72 CNY | +0.78% | -4.46% | -27.10% |
Business Summary
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Cardiovascular and Cerebrovascular Medications
51.9
%
| 294 | 40.0 % | 248 | 51.9 % | -15.86% |
Immune System Medications
35.6
%
| 358 | 48.8 % | 169 | 35.6 % | -52.69% |
Nervous System Medications
11.7
%
| 77 | 10.5 % | 56 | 11.7 % | -27.41% |
Other Medicines, Other
0.8
%
| 5 | 0.7 % | 4 | 0.8 % | -28.37% |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 735 | 100.0 % | 477 | 100.0 % | -35.12% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Biao Ma
CEO | Chief Executive Officer | 60 | 01-07-04 |
Ning Zhang
ADM | Chief Administrative Officer | 45 | 21-01-27 |
Meng Wei Song
CTO | Chief Tech/Sci/R&D Officer | 49 | 01-02-28 |
Li Ma
BRD | Director/Board Member | 55 | 05-09-30 |
Xue Feng Wang
BRD | Director/Board Member | 46 | 98-12-31 |
Sheng Nan Ma
IRC | Investor Relations Contact | - | - |
Yin Fu Shen
SAM | Sales & Marketing | 59 | 21-01-27 |
Shuang Quan Kong
PRN | Corporate Officer/Principal | 50 | 04-06-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Yan Heng Song
BRD | Director/Board Member | 51 | 01-25 |
Xue Feng Wang
BRD | Director/Board Member | 46 | 98-12-31 |
Biao Ma
CEO | Chief Executive Officer | 60 | 01-07-04 |
Meng Wei Song
CTO | Chief Tech/Sci/R&D Officer | 49 | 01-02-28 |
Li Ma
BRD | Director/Board Member | 55 | 05-09-30 |
Wen Tao Xu
BRD | Director/Board Member | 45 | - |
Li Na Zhao
CHM | Chairman | 63 | - |
Chang Chen Yin
BRD | Director/Board Member | 53 | 21-01-27 |
Ning Zhang
ADM | Chief Administrative Officer | 45 | 21-01-27 |
Yun Ping Dai
BRD | Director/Board Member | 61 | 01-25 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 481,666,400 | 198,339,809 ( 41.18 %) | 0 | 41.18 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
13,751,500 | 6.79% | 49,230,508 $ |
Company contact information
Beijing Science Sun Pharmaceutical Co., Ltd.
8 Xingsheng Street Beijing Economic & Tech Dev Zone
100176, Beijing
+
http://www.ssyy.com.cnSector
Sales per Business
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-27.10% | 515M | |
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |
- Stock Market
- Equities
- 300485 Stock
- Company Beijing Science Sun Pharmaceutical Co., Ltd.